12709465

Source:http://linkedlifedata.com/resource/pubmed/id/12709465

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0007226, umls-concept:C0008976, umls-concept:C0042523, umls-concept:C0332162, umls-concept:C0401925, umls-concept:C1261322, umls-concept:C1274040, umls-concept:C2349179, umls-concept:C2587213
pubmed:issue	16
pubmed:dateCreated	2003-4-23
pubmed:abstractText	Hypertensive patients are often given a calcium antagonist to reduce cardiovascular disease risk, but the benefit compared with other drug classes is controversial.
pubmed:commentsCorrections	http://linkedlifedata.com/resource/pubmed/commentcorrection/12709465-12709471, http://linkedlifedata.com/resource/pubmed/commentcorrection/12709465-14594425
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7501160
pubmed:citationSubset	AIM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Adrenergic beta-Antagonists, http://linkedlifedata.com/resource/pubmed/chemical/Antihypertensive Agents, http://linkedlifedata.com/resource/pubmed/chemical/Atenolol, http://linkedlifedata.com/resource/pubmed/chemical/Calcium Channel Blockers, http://linkedlifedata.com/resource/pubmed/chemical/Delayed-Action Preparations, http://linkedlifedata.com/resource/pubmed/chemical/Diuretics, http://linkedlifedata.com/resource/pubmed/chemical/Hydrochlorothiazide, http://linkedlifedata.com/resource/pubmed/chemical/Sodium Chloride Symporter Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Vasodilator Agents, http://linkedlifedata.com/resource/pubmed/chemical/Verapamil
pubmed:status	MEDLINE
pubmed:issn	0098-7484
pubmed:author	pubmed-author:AndersRobert JRJ, pubmed-author:BlackHenry RHR, pubmed-author:CONVINCE Research Group, pubmed-author:ElliottWilliam JWJ, pubmed-author:GrambschPatriciaP, pubmed-author:GranditsGregoryG, pubmed-author:GrimmRichard HRHJr, pubmed-author:HanssonLennartL, pubmed-author:LacourciereYvesY, pubmed-author:LucenteTracyT, pubmed-author:MullerJamesJ, pubmed-author:NeatonJames DJD, pubmed-author:SleightPeterP, pubmed-author:WeberMichael AMA, pubmed-author:WhiteWilliam BWB, pubmed-author:WilliamsGordonG, pubmed-author:WittesJanetJ, pubmed-author:ZanchettiAlbertoA
pubmed:issnType	Print
pubmed:volume	289
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	2073-82
pubmed:dateRevised	2007-11-15
pubmed:meshHeading	pubmed-meshheading:12709465-Adrenergic beta-Antagonists, pubmed-meshheading:12709465-Aged, pubmed-meshheading:12709465-Antihypertensive Agents, pubmed-meshheading:12709465-Atenolol, pubmed-meshheading:12709465-Calcium Channel Blockers, pubmed-meshheading:12709465-Cardiovascular Diseases, pubmed-meshheading:12709465-Delayed-Action Preparations, pubmed-meshheading:12709465-Diabetes Mellitus, pubmed-meshheading:12709465-Diuretics, pubmed-meshheading:12709465-Double-Blind Method, pubmed-meshheading:12709465-Female, pubmed-meshheading:12709465-Humans, pubmed-meshheading:12709465-Hydrochlorothiazide, pubmed-meshheading:12709465-Hypertension, pubmed-meshheading:12709465-Male, pubmed-meshheading:12709465-Middle Aged, pubmed-meshheading:12709465-Myocardial Infarction, pubmed-meshheading:12709465-Risk Factors, pubmed-meshheading:12709465-Smoking, pubmed-meshheading:12709465-Sodium Chloride Symporter Inhibitors, pubmed-meshheading:12709465-Stroke, pubmed-meshheading:12709465-Survival Analysis, pubmed-meshheading:12709465-Vasodilator Agents, pubmed-meshheading:12709465-Verapamil
pubmed:articleTitle	Principal results of the Controlled Onset Verapamil Investigation of Cardiovascular End Points (CONVINCE) trial.
pubmed:affiliation	Rush Medical College of Rush University, Chicago, IL 60612, USA. hblack@rush.edu
pubmed:publicationType	Journal Article, Clinical Trial, Comparative Study, Randomized Controlled Trial, Research Support, Non-U.S. Gov't, Multicenter Study